Bayer Healthcare Licenses Animal Ethics Pain Management Product Tri-Solfen® in Australia “A groundbreaking anaesthetic for a painful animal husbandry practice has won the backing of a global pharmaceutical giant”… “Multinational pharmaceutical company Bayer recently announced it had taken over the licensing and marketing of the treatment”.
– Ends –
About Medical Ethics
Medical Ethics is a commercial and development stage company focused on pain mitigation in wounds for humans and animals.
Through our proven patent protected platform technology, we have identified a transformational way of mitigating pain and minimising suffering associated with wounds.
Tri-Solfen® is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting Bupivacaine for prolonged post-operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.
Allan Giffard, Managing Director
Charles Olsson, Marketing Director
+61 419 362 286
Brett Pollard, Victoria Foster Mitchell
+44 (0)20 3727 1000